Cite
HARVARD Citation
Palomba, M. et al. (2022). CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience. Journal for immunotherapy of cancer. 10 (2), p. . [Online].